Skip to main content
. Author manuscript; available in PMC: 2021 Nov 23.
Published in final edited form as: Angew Chem Int Ed Engl. 2020 Sep 17;59(48):21634–21639. doi: 10.1002/anie.202007953

Figure 3.

Figure 3.

Development of enantiodivergent biocatalysts. The diagram shows the evolutionary paths leading to the (1R,6R,7R)-selective myoglobin variants for the synthesis of 3a from 1a. The bar graphs report the GC yields of the reactions with the different variants. See Table S3 for further details.